Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Oklahoma reconsidering Medicaid expansion

Republican leaders argue Medicaid "rebalancing" isn't the same as what was initially offered under the Affordable Care Act.

Ex-HHS official: HIPAA must keep up with mobile health

The federal regulatory environment has not kept pace with the progress of mobile health, which is driven by consumers who expect to have all sorts of information, including health data, on their phones, said Jeffrey Dunifon, an associate attorney at Baker & Mckenzie who previously was an investigator at the Department of Health and Human Services Office for Civil Rights.

HHS finalizes anti-discrimination rule

HHS clarifies that protections against gender discrimination included in the Affordable Care Act apply to gender identity.

FDA changes warning label on fluoroquinolones

Safety review of the drugs associated their use with “disabling and potentially permanent serious side effects” involving tendons, muscles, joints, nerves and the central nervous system.

What we know about Republicans’ ACA replacement

New proposal would include changes to Medicare and Medicaid, but won't be released as actual legislation ahead of the Republican National Convention.

Patients use ProPublica database to find painkiller prescriptions

The investigative news outlet announced its database to track the prescribing habits of doctors has been used by some to find addictive painkillers.

4 changes AHA wants from CMS in implementing new payment system

The American Hospital Association recommended several changes from the proposed requirements in written testimony submitted to the House Ways and Means Committee.

Judge rules Obama admin improperly funding ACA subsidy

A federal judge has ruled HHS and the U.S. Treasury Department don’t have the power to spend funds for reducing deductibles, co-pays and other “cost-sharing” means by insurers without congressional approval.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup